Stella Pharma Corporation (TYO:4888)
431.00
-1.00 (-0.23%)
Nov 18, 2026, 10:00 AM JST
Stella Pharma Market Cap
Stella Pharma has a market cap or net worth of 16.39 billion as of November 17, 2026. It is the 24,636th most valuable company in the world and the 2,068th biggest in Japan. Its market cap has increased by 97.40% in one year.
Market Cap
16.39B
Enterprise Value
13.44B
Revenue
298.00M
Global Rank
Country Rank
#2,068 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since April 22, 2021, Stella Pharma's market cap has decreased from 23.73B to 16.39B, a decrease of -30.92%. That is a compound annual growth rate of -6.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 16.39B | 137.27% |
| Dec 30, 2025 | 6.91B | -62.20% |
| Dec 30, 2024 | 18.28B | 105.37% |
| Dec 29, 2023 | 8.90B | -22.42% |
| Dec 30, 2022 | 11.47B | -56.48% |
| Dec 30, 2021 | 26.35B | 11.06% |
| Apr 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Innovacell | 22.58B |
| RaQualia Pharma | 16.82B |
| CanBas | 13.94B |
| ReproCELL | 11.64B |
| AnGes | 10.94B |
| Kubota Pharmaceutical Holdings | 8.59B |
| Immuno-Biological Laboratories | 8.54B |
| K Pharma,Inc. | 7.72B |